Cytokinetics, Incorporated is a company in the U.S. stock market and it is a holding in 56 U.S.-traded ETFs. CYTK has around 9.8M shares in the U.S. ETF market. The largest ETF holder of CYTK is the iShares Core S&P Small-Cap ETF (IJR), with approximately 3.72M shares. Investors may also find of interest that the ETF with the largest allocation to CYTK stock is Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a portfolio weight of 0.85%. On average, U.S. ETFs allocate 0.08% of CYTK to their portfolios.
Additionally, CYTK is a favorite stock for Vanilla and Value ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with CYTK as a holding is the Invesco DWA NASDAQ Momentum ETF (DWAQ), with a return of 17.61%.